InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
6
T+90 hit rate
100%
T+90 mean return
+16.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Lalwani Nikhil, Chairman & CEO. Officer active across 1 company, notably ANI Pharmaceuticals INC. In total, 34 disclosures have been recorded. Split: 1 buy · 6 sells. Total volume traded: €11.1m. Activity tracked since 8 September 2021. The latest transaction was disclosed on 25 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lalwani Nikhil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations34 total
5,400 shares@ US$74.30Common StockSEC:0001822629-26-000014:0
17,060 shares@ US$74.040.061% mcap6.3% of flowCommon StockSEC:0001822629-26-000008:0
75,592 shares@ US$77.1517.5% of flowCommon StockSEC:0001822629-26-000006:0
11,688 shares@ US$76.704.4% of flowCommon StockSEC:0001822629-26-000004:0
10,298 shares@ US$77.363.9% of flowCommon StockSEC:0001822629-26-000004:1
30,659 shares@ US$76.257.0% of flowCommon StockSEC:0001822629-26-000002:0
56,960 shares@ US$85.9319.6% of flowCommon StockSEC:0001822629-25-000010:0
17,455 shares@ US$64.266.0% of flowCommon StockSEC:0001822629-25-000008:0
17,060 shares@ US$60.625.6% of flowCommon StockSEC:0001822629-25-000006:0
12,216 shares@ US$61.894.2% of flowCommon StockSEC:0001822629-25-000004:0
7,799 shares@ US$58.922.5% of flowCommon StockSEC:0001822629-25-000002:2
91,399 shares0Common StockSEC:0001822629-25-000002:0
60,932 shares0Common StockSEC:0001822629-25-000002:1
30,000 shares@ US$29.004.8% of flowCommon StockSEC:0001822629-24-000014:0
3,646 shares@ US$60.511.2% of flowCommon StockSEC:0001822629-24-000012:0
16,669 shares@ US$66.105.9% of flowCommon StockSEC:0001822629-24-000010:0
17,455 shares@ US$69.586.5% of flowCommon StockSEC:0001822629-24-000008:0
28,965 shares@ US$65.5210.1% of flowCommon StockSEC:0001822629-24-000006:0
10,014 shares@ US$67.673.6% of flowCommon StockSEC:0001822629-24-000004:0
80,530 shares0Common StockSEC:0001822629-24-000002:0
3,646 shares@ US$61.941.2% of flowCommon StockSEC:0001822629-23-000004:0
56,666 shares@ US$57.7517.3% of flowCommon StockSEC:0001822629-23-000002:0
11,616 shares@ US$29.001.8% of flowCommon StockSEC:0001822629-23-000002:1
11,616 shares@ US$61.133.8% of flowCommon StockSEC:0001822629-23-000002:2
95,530 shares0Common StockSEC:0001104659-23-041742:0
25 of 34 declarations
About Lalwani Nikhil
Lalwani Nikhil is President & CEO at ANI Pharmaceuticals INC, listed on XNAS. He has 33 filings in total, and in the most recent filings we hold, purchases amount to EUR 181105 and sales to EUR 10589734, between 2021-09-10 and 2026-03-10, with the main transaction nature indicated as Tax withholding.
